Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.

Smith JS, Bailey RC, Westreich DJ, Maclean I, Agot K, Ndinya-Achola JO, Hogrefe W, Morrow RA, Moses S.

Sex Transm Infect. 2009 Apr;85(2):92-6. doi: 10.1136/sti.2008.031815. Epub 2008 Oct 27.

2.

Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.

Ngo TD, Laeyendecker O, La H, Hogrefe W, Morrow RA, Quinn TC.

Clin Vaccine Immunol. 2008 Feb;15(2):382-4. Epub 2007 Dec 12.

3.

Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.

Benjamin RJ, Busch MP, Fang CT, Notari EP, Puren A, Schoub BD, Tobler LH, Hogrefe W, du P Heyns A, Stramer SL, Crookes RL.

Transfusion. 2008 Feb;48(2):295-303. Epub 2007 Nov 13.

PMID:
18005322
4.

Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.

Laderman EI, Whitworth E, Dumaual E, Jones M, Hudak A, Hogrefe W, Carney J, Groen J.

Clin Vaccine Immunol. 2008 Jan;15(1):159-63. Epub 2007 Nov 14.

6.
7.

Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test.

Philipp MT, Masters E, Wormser GP, Hogrefe W, Martin D.

Clin Vaccine Immunol. 2006 Oct;13(10):1170-1.

8.
9.

Biomarkers and assessment of vaccine responses.

Hogrefe WR.

Biomarkers. 2005 Nov;10 Suppl 1:S50-7. Review.

PMID:
16298912
11.

Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Laeyendecker O, Henson C, Gray RH, Nguyen RH, Horne BJ, Wawer MJ, Serwadda D, Kiwanuka N, Morrow RA, Hogrefe W, Quinn TC.

J Clin Microbiol. 2004 Apr;42(4):1794-6.

12.

Human monocytotropic ehrlichiosis, Missouri.

Olano JP, Masters E, Hogrefe W, Walker DH.

Emerg Infect Dis. 2003 Dec;9(12):1579-86.

13.
14.
17.

Prevalence study of antibody to ratborne pathogens and other agents among patients using a free clinic in downtown Los Angeles.

Smith HM, Reporter R, Rood MP, Linscott AJ, Mascola LM, Hogrefe W, Purcell RH.

J Infect Dis. 2002 Dec 1;186(11):1673-6. Epub 2002 Nov 1.

PMID:
12447746
20.
21.

Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies.

García-Corbeira P, Hogrefe W, Aguilar L, García-de-Lomas J, Gil A, Bayas JM, Vilella A, Dal-Ré R.

J Med Virol. 1999 Dec;59(4):502-6.

PMID:
10534733
22.

A further case of acute human granulocytic ehrlichiosis in Slovenia.

Laferl H, Hogrefe W, Köck T, Pichler H.

Eur J Clin Microbiol Infect Dis. 1999 May;18(5):385-6. No abstract available.

PMID:
10421051
23.
24.

Parvovirus B19-antibody serosurvey in 500 developmentally disabled subjects.

Lohiya GS, Hogrefe W, Tan-Figueroa L, Caires S.

Infect Control Hosp Epidemiol. 1997 May;18(5):340-2.

PMID:
9154477
25.
26.

Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection.

Murray JC, Kelley PK, Hogrefe WR, McClain KL.

Am J Pediatr Hematol Oncol. 1994 Nov;16(4):314-9.

PMID:
7978048
27.

Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection.

Liegner KB, Shapiro JR, Ramsay D, Halperin AJ, Hogrefe W, Kong L.

J Am Acad Dermatol. 1993 Feb;28(2 Pt 2):312-4.

PMID:
8436647
28.

Immunoglobulins in hemophilia: correlation between IgG subclasses, IgE and HIV antibody.

Kumar A, Gera R, Kulkarni R, Hogrefe WR, Kaufman DB.

J Clin Lab Immunol. 1990 Apr;31(4):157-60.

PMID:
1967059
29.

Biotreatment of s-triazine-containing wastewater in a fluidized bed reactor.

Hogrefe W, Grossenbacher H, Cook AM, Hütter R.

Biotechnol Bioeng. 1986 Oct;28(10):1577-81.

PMID:
18553875
30.

Biological treatment specific for an industrial wastewater containing s-triazines.

Hogrefe W, Grossenbacher H, Cook AM, Hütter R.

Biotechnol Bioeng. 1985 Sep;27(9):1291-6.

PMID:
18553817
31.

Small-cell lymphoma and Sjögren's syndrome. Lymphoplasmacytic subvariant of small-cell lymphoma with IgA/kappa immunoglobulin surface markers.

Askari AD, Laqui CC, Rassiga AL, Hogrefe WR, Laipply TC.

Arch Intern Med. 1985 May;145(5):935-7.

PMID:
3922321
32.

Evidence that peritoneal lymphocytes are not related to the recirculating pool of lymphocytes.

Catanzaro PH, Agniel LD Jr, Hogrefe WR, Phillips SM.

J Reticuloendothel Soc. 1978 Jun;23(6):459-68. No abstract available.

PMID:
702471
33.

Interaction of peritoneal exudate lymphocytes with histocompatibility antigens.

Catanzaro PJ, Agniel LD, Hogrefe WR, Phillips SM.

Cell Immunol. 1977 Mar 15;29(2):394-402. No abstract available.

PMID:
140768
34.

Virus-enhanced modulation of cell surface antigens: effect on immune lytic susceptibility.

Catanzaro PJ, Brandt WE, Hogrefe WR, Phillips SM, Top FH Jr.

J Immunol. 1976 Oct;117(4):1104-10.

PMID:
61990
35.

Mouse peritoneal lymphocytes: a morphologic comparison of normal and exudate peritoneal lymphocytes.

Catanzaro PJ, Graham RC Jr, Hogrefe WR.

J Reticuloendothel Soc. 1974 Sep;16(3):161-74. No abstract available.

PMID:
4549076
36.

Detection of dengue cell-surface antigens by peroxidase-labeled antibodies and immune cytolysis.

Catanzaro PJ, Brandt WE, Hogrefe WR, Russell PK.

Infect Immun. 1974 Aug;10(2):381-8.

Supplemental Content

Loading ...
Support Center